{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:14:37Z","timestamp":1787858077861,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2307700"],"award-info":[{"award-number":["2023YFC2307700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B18035"],"award-info":[{"award-number":["B18035"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20811"],"award-info":[{"award-number":["U24A20811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0753"],"award-info":[{"award-number":["2024NSFSC0753"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114889","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:54:12Z","timestamp":1774972452000},"page":"114889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Biomineralized nanoemulsion delivers mRNA for potent cancer immunotherapy"],"prefix":"10.1016","volume":"394","author":[{"given":"Yanhua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jconrel.2026.114889_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114889_bb0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114889_bb0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41573-024-01081-5","article-title":"Vaccines for cancer prevention: exploring opportunities and navigating challenges","volume":"24","author":"Graciotti","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114889_bb0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2022.02.027","article-title":"Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy","volume":"344","author":"Bai","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.apsb.2023.06.006","article-title":"Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114889_bb0030","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials on mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114889_bb0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting antitumor immunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114889_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"MRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114889_bb0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"MRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8060","key":"10.1016\/j.jconrel.2026.114889_bb0055","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1038\/d41586-025-01151-7","article-title":"MRNA technology helps reinvigorate the hunt for cancer vaccines","volume":"640","author":"Nogrady","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114889_bb0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41587-025-02708-7","article-title":"Individualized mRNA cancer vaccines make strides","volume":"43","author":"Sheridan","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114889_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2024.04.039","article-title":"Emerging advances in delivery systems for mRNA cancer vaccines","volume":"370","author":"Jiang","year":"2024","journal-title":"J. Control. Release"},{"issue":"7823","key":"10.1016\/j.jconrel.2026.114889_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01457-x","article-title":"Clinical development of mRNA therapies against solid tumors","volume":"16","author":"Wu","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114889_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41591-023-02760-3","article-title":"Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial","volume":"30","author":"Pant","year":"2024","journal-title":"Nat. Med."},{"issue":"10427","key":"10.1016\/j.jconrel.2026.114889_bb0085","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (v940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.11.015","article-title":"Clinical advances of mRNA vaccines for cancer immunotherapy","volume":"6","author":"Yaremenko","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.jconrel.2026.114889_bb0095","article-title":"Cancer vaccines: discovery, development, and challenges for clinical translation","volume":"325","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114889_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217752","article-title":"Cancer mRNA vaccines: clinical application progress and challenges","volume":"625","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114889_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114889_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2026.114889_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estape Senti","year":"2022","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114889_bb0120","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"issue":"50","key":"10.1016\/j.jconrel.2026.114889_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114889_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1294929","article-title":"Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design","volume":"14","author":"Clemente","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114889_bb0135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jiac.2021.12.034","article-title":"Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan","volume":"28","author":"Kitagawa","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jconrel.2026.114889_bb0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2022.07.032","article-title":"Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses","volume":"349","author":"Chen","year":"2022","journal-title":"J. Control. Release"},{"issue":"17\u201319","key":"10.1016\/j.jconrel.2026.114889_bb0145","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0264-410X(00)00499-0","article-title":"The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine","volume":"19","author":"Podda","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114889_bb0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/aje\/kws313","article-title":"Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy","volume":"176","author":"Mannino","year":"2012","journal-title":"Am. J. Epidemiol."},{"issue":"39","key":"10.1016\/j.jconrel.2026.114889_bb0155","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1016\/j.vaccine.2014.07.013","article-title":"Comparison of the safety and immunogenicity of an MF59(R)-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects","volume":"32","author":"Frey","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00418-0","article-title":"\u201cWorld in motion\u201d - emulsion adjuvants rising to meet the pandemic challenges","volume":"6","author":"O\u2019Hagan","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114889_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.gt.3300390","article-title":"Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Porteous","year":"1997","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114889_bb0170","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.apsb.2021.08.011","article-title":"Inhibiting collagen i production and tumor cell colonization in the lung via miR-29a-3p loading of exosome\u2212\/liposome-based nanovesicles","volume":"12","author":"Yan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114889_bb0175","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.apsb.2022.08.015","article-title":"Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine","volume":"13","author":"Duan","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114889_bb0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","article-title":"Cancer nanomedicine toward clinical translation: obstacles, opportunities, and future prospects","volume":"4","author":"Zhang","year":"2023","journal-title":"Med"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114889_bb0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114889_bb0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114889_bb0195","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.114889_bb0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2025.01.009","article-title":"Antigens and adjuvants co-stabilized Pickering emulsions amplify immune responses of subunit vaccines","volume":"379","author":"Guo","year":"2025","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114889_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412627","article-title":"Metalloparticle-engineered pickering emulsion displaying AAV-vectored vaccine for enhancing antigen expression and immunogenicity against pathogens","volume":"37","author":"Guo","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114889_bb0210","series-title":"Lipid Nanoparticles for mRNA-Mediated cancer Therapy","first-page":"158","author":"Grant-Serroukh","year":"2019"},{"key":"10.1016\/j.jconrel.2026.114889_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114082","article-title":"Structural characterization of mRNA lipid nanoparticles (LNPs) in the presence of mRNA-free LNPs","volume":"386","author":"Chen","year":"2025","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114889_bb0220","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation","volume":"18","author":"Paunovska","year":"2018","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114889_bb0225","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1023\/A:1016480421204","article-title":"Effect of non-ionic surfactants on the formation of DNA\/emulsion complexes and emulsion-mediated gene transfer","volume":"13","author":"Liu","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114889_bb0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"33","key":"10.1016\/j.jconrel.2026.114889_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114889_bb0240","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of t cell biology in autoimmunity and cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114889_bb0245","doi-asserted-by":"crossref","first-page":"14607","DOI":"10.1038\/ncomms14607","article-title":"IFN-gamma is required for cytotoxic t cell-dependent cancer genome immunoediting","volume":"8","author":"Takeda","year":"2017","journal-title":"Nat. Commun."},{"issue":"40","key":"10.1016\/j.jconrel.2026.114889_bb0250","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1073\/pnas.0405947101","article-title":"IFN-gamma enables cross-presentation of exogenous protein antigen in human langerhans cells by potentiating maturation","volume":"101","author":"Matsuo","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.immuni.2008.11.006","article-title":"The phagosomal proteome in interferon-gamma-activated macrophages","volume":"30","author":"Trost","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114889_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102499","article-title":"CD137 \/ CD137 ligand signalling regulates the immune balance: a potential target for novel immunotherapy of autoimmune diseases","volume":"112","author":"Wong","year":"2020","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114889_bb0265","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) t cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114889_bb0270","first-page":"63","article-title":"NK cell-based tumor immunotherapy","volume":"31","author":"Zhang","year":"2024","journal-title":"Bioact. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114889_bb0275","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114889_bb0280","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2147\/IJN.S363990","article-title":"Optimization of lipid nanoformulations for effective mRNA delivery","volume":"17","author":"Chen","year":"2022","journal-title":"Int. J. Nanomedicine"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114889_bb0285","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2026.114889_bb0290","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(01)00534-X","article-title":"Chemical hydrolysis of DOTAP and DOPE in a liposomal environment","volume":"79","author":"Vernooij","year":"2002","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114889_bb0295","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1002\/jcb.28196","article-title":"Targeting of high mobility group a2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells","volume":"120","author":"Mohammadi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010008","article-title":"Influence of lipid composition of cationic liposomes 2X3-DOPE on mRNA delivery into eukaryotic cells","volume":"15","author":"Vysochinskaya","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0305","article-title":"Regulating immune responses induced by PEGylated messenger RNA-lipid nanoparticle vaccine","volume":"13","author":"Jo","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"42","key":"10.1016\/j.jconrel.2026.114889_bb0310","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.vaccine.2022.08.024","article-title":"MRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations","volume":"40","author":"Carreno","year":"2022","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.jconrel.2026.114889_bb0315","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114889_bb0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/dna.2006.25.393","article-title":"Transfer RNA binding to human serum albumin: a model for protein-RNA interaction","volume":"25","author":"Malonga","year":"2006","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114889_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114238","article-title":"SitoC7A-modified lipid nanoparticles for integrated mRNA delivery and targeted STING activation","volume":"387","author":"Qiao","year":"2025","journal-title":"J. Control. Release"},{"issue":"7830","key":"10.1016\/j.jconrel.2026.114889_bb0330","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114889_bb0335","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114889_bb0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2020.03.006","article-title":"Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein e\/low density lipoprotein receptor and the n-acetyl-d-galactosamine\/asialoglycoprotein receptor pathway","volume":"322","author":"Sato","year":"2020","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:56:21Z","timestamp":1779756981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":68,"alternative-id":["S0168365926002919"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114889","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomineralized nanoemulsion delivers mRNA for potent cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114889"}}